PLASMA KALLIKREIN INHIBITORS
The present invention provides a compound of Formula Iand pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioe...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TIAN, Maoqun HICKS, Jacqueline, D ZHAO, Zhiqiang SINZ, Christopher, J SHARP, Phillip Patrick SHEARN-NANCE, Galen Paul LOMBARDO, Matthew, J BAO, Jianming KUANG, Rongze LOPEZ, Jovan Alexander CHENG, Alan, C YANG, Song WU, Zhicai MERCHANT, Rohan |
| description | The present invention provides a compound of Formula Iand pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age related macular edema, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4178620A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4178620A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4178620A13</originalsourceid><addsrcrecordid>eNrjZJAJ8HEM9nVU8Hb08fH0DnL19FPw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJobmFmZGBo6GxkQoAQA8WiCC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PLASMA KALLIKREIN INHIBITORS</title><source>esp@cenet</source><creator>TIAN, Maoqun ; HICKS, Jacqueline, D ; ZHAO, Zhiqiang ; SINZ, Christopher, J ; SHARP, Phillip Patrick ; SHEARN-NANCE, Galen Paul ; LOMBARDO, Matthew, J ; BAO, Jianming ; KUANG, Rongze ; LOPEZ, Jovan Alexander ; CHENG, Alan, C ; YANG, Song ; WU, Zhicai ; MERCHANT, Rohan</creator><creatorcontrib>TIAN, Maoqun ; HICKS, Jacqueline, D ; ZHAO, Zhiqiang ; SINZ, Christopher, J ; SHARP, Phillip Patrick ; SHEARN-NANCE, Galen Paul ; LOMBARDO, Matthew, J ; BAO, Jianming ; KUANG, Rongze ; LOPEZ, Jovan Alexander ; CHENG, Alan, C ; YANG, Song ; WU, Zhicai ; MERCHANT, Rohan</creatorcontrib><description>The present invention provides a compound of Formula Iand pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age related macular edema, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230517&DB=EPODOC&CC=EP&NR=4178620A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230517&DB=EPODOC&CC=EP&NR=4178620A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TIAN, Maoqun</creatorcontrib><creatorcontrib>HICKS, Jacqueline, D</creatorcontrib><creatorcontrib>ZHAO, Zhiqiang</creatorcontrib><creatorcontrib>SINZ, Christopher, J</creatorcontrib><creatorcontrib>SHARP, Phillip Patrick</creatorcontrib><creatorcontrib>SHEARN-NANCE, Galen Paul</creatorcontrib><creatorcontrib>LOMBARDO, Matthew, J</creatorcontrib><creatorcontrib>BAO, Jianming</creatorcontrib><creatorcontrib>KUANG, Rongze</creatorcontrib><creatorcontrib>LOPEZ, Jovan Alexander</creatorcontrib><creatorcontrib>CHENG, Alan, C</creatorcontrib><creatorcontrib>YANG, Song</creatorcontrib><creatorcontrib>WU, Zhicai</creatorcontrib><creatorcontrib>MERCHANT, Rohan</creatorcontrib><title>PLASMA KALLIKREIN INHIBITORS</title><description>The present invention provides a compound of Formula Iand pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age related macular edema, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJ8HEM9nVU8Hb08fH0DnL19FPw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJobmFmZGBo6GxkQoAQA8WiCC</recordid><startdate>20230517</startdate><enddate>20230517</enddate><creator>TIAN, Maoqun</creator><creator>HICKS, Jacqueline, D</creator><creator>ZHAO, Zhiqiang</creator><creator>SINZ, Christopher, J</creator><creator>SHARP, Phillip Patrick</creator><creator>SHEARN-NANCE, Galen Paul</creator><creator>LOMBARDO, Matthew, J</creator><creator>BAO, Jianming</creator><creator>KUANG, Rongze</creator><creator>LOPEZ, Jovan Alexander</creator><creator>CHENG, Alan, C</creator><creator>YANG, Song</creator><creator>WU, Zhicai</creator><creator>MERCHANT, Rohan</creator><scope>EVB</scope></search><sort><creationdate>20230517</creationdate><title>PLASMA KALLIKREIN INHIBITORS</title><author>TIAN, Maoqun ; HICKS, Jacqueline, D ; ZHAO, Zhiqiang ; SINZ, Christopher, J ; SHARP, Phillip Patrick ; SHEARN-NANCE, Galen Paul ; LOMBARDO, Matthew, J ; BAO, Jianming ; KUANG, Rongze ; LOPEZ, Jovan Alexander ; CHENG, Alan, C ; YANG, Song ; WU, Zhicai ; MERCHANT, Rohan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4178620A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>TIAN, Maoqun</creatorcontrib><creatorcontrib>HICKS, Jacqueline, D</creatorcontrib><creatorcontrib>ZHAO, Zhiqiang</creatorcontrib><creatorcontrib>SINZ, Christopher, J</creatorcontrib><creatorcontrib>SHARP, Phillip Patrick</creatorcontrib><creatorcontrib>SHEARN-NANCE, Galen Paul</creatorcontrib><creatorcontrib>LOMBARDO, Matthew, J</creatorcontrib><creatorcontrib>BAO, Jianming</creatorcontrib><creatorcontrib>KUANG, Rongze</creatorcontrib><creatorcontrib>LOPEZ, Jovan Alexander</creatorcontrib><creatorcontrib>CHENG, Alan, C</creatorcontrib><creatorcontrib>YANG, Song</creatorcontrib><creatorcontrib>WU, Zhicai</creatorcontrib><creatorcontrib>MERCHANT, Rohan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TIAN, Maoqun</au><au>HICKS, Jacqueline, D</au><au>ZHAO, Zhiqiang</au><au>SINZ, Christopher, J</au><au>SHARP, Phillip Patrick</au><au>SHEARN-NANCE, Galen Paul</au><au>LOMBARDO, Matthew, J</au><au>BAO, Jianming</au><au>KUANG, Rongze</au><au>LOPEZ, Jovan Alexander</au><au>CHENG, Alan, C</au><au>YANG, Song</au><au>WU, Zhicai</au><au>MERCHANT, Rohan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PLASMA KALLIKREIN INHIBITORS</title><date>2023-05-17</date><risdate>2023</risdate><abstract>The present invention provides a compound of Formula Iand pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age related macular edema, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4178620A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | PLASMA KALLIKREIN INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T11%3A01%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TIAN,%20Maoqun&rft.date=2023-05-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4178620A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |